Abstract:Background: HBV-specific cytotoxic T lymphocyte (CTL) activity is believed to play a critical role in controlling HBV infection. The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway manipulates cell fate decisions in many different cell types by regulating the activity of downstream effectors. We have previously testified that the fusion protein of CTP-HBcAg18-27-Tapasin could enter the cytoplasm of dendritic cells and efficiently induce robust specific CTL response in vitro.Objectives: In the present study, we evaluated specific CTL response and the level of apoptosis of CD8+ T cells induced by CTP-HBcAg18-27-Tapasin in HLA-A2 transgenic mice (H-2Kb). Meanwhile, we preliminary investigated PI3K, phosphorylation level of Akt, and mammalian target of rapamycin (mTOR) as positive regulator of the magnitude and effector function of the hepatitis B virus-specific cytotoxic T lymphocytes in HLA-A2 transgenic mice.Materials and Methods: HLA-A2 transgenic mice were immunized by intramuscular injection in the hind legs three times at one-week intervals with PBS, CTP-HBcAg18-27-Tapasin (50 mu g), CTP-HBcAg18-27 (50 mu g), HBcAg18-27-Tapasin (50 mu g), and HBcAg18-27 (50 mu g). One week after the last immunization, mice were sacrificed and splenocytes were harvested in strile condition. The specific CTL response was analyzed by flow cytometry and enzyme linked immunosorbent assay (ELISA); the expression of (PI3K)/Akt signaling was detected by RTPCR and western blot.Results: The results showed that CTP-HBcAg18-27-Tapasin significantly increased the percentages of IFN-gamma(+) CD8 alpha(+) T cells, the numbers of these polyfunctional triple-cytokine-producing (IFN-gamma, TNF-alpha, and IL-2) CD8(+)T cells, the secretion of cytokine IFN-gamma, IL-2, and TNF-alpha, while in comparison to control group, it significantly decreased the percentage of apoptotic CD8(+) T cells in HLA-A2 transgenic mice. Moreover, the expression of PI3K, P-Akt, and P-mTOR was significantly upregulated in CTP-HBcAg18-27-Tapasin group compared with control groups.Conclusions: In conclusion, CTP-HBcAg18-27-Tapasin could reduce apoptosis of CD8(+) T cells, increase the percentages of IFN-gamma(+) CD8a(+) T cells, and elicit cell-mediated immunity in HLA-A2 transgenic mice; these processes were associated with activation of the PI3K/Akt signaling pathway.

Transmission Functions of Fusion Protein CTP-HBcAg18-27-Tapasin in the Cells

Effects of cytoplasmic transduction peptide-HBcAg18-27-Tapasin induced murine bone marrow derived dendritic cell maturation on T lymphocyte proliferation in vitro

Trans-activator of transcription protein transduction domain mediated cell membrane penetration of HBcAg

The fusion protein of cytoplasmic transduction peptide (CTP)-HBcAg18-27-Tapasin enhances specific immune response to hepatitis B virus and inhibits viral replication in transgenic mice

[Secretion of Th1-type Cytokines and Production of HBV-specific Cytotoxic T Lymphocytes in C57BL/6 Mice Induced by Cytoplasmic Transduction Peptide-Hbcag18-27-tapasin].

The Fusion Protein of Ctp-Hbcag18-27-Tapasin Mediates the Apoptosis of Cd8+T Cells and Cd8+T Cell Response in Hla-A2 Transgenic Mice

The Modification of Tapasin Enhances Cytotoxic T Lymphocyte Activity of Intracellularly Delivered CTL Epitopes Via Cytoplasmic Transduction Peptide

Enhancement of Cytotoxic T Lymphocyte Activity by Dendritic Cells Loaded with Tat-protein Transduction Domain-Fused Hepatitis B Virus Core Antigen

Possible Mecanism of Transmembrane of TAT-PTD Fusion Protein

TAT Protein Transduction Domain Mediates Transmembrane Delivery of EGFP into Tissue Cells of Mice in Vivo

Construction,expression and purification of recombinant plasmid of fusion protein CTP-HBcAg_(18-27)-Tapasin

Tapasin modification on the intracellular epitope HBcAg 18–27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo

Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells

Fusion Protein of Tapasin and Hepatitis B Core Antigen 18-27 Enhances T Helper Cell Type 1/2 Cytokine Ratio and Antiviral Immunity by Inhibiting Suppressors of Cytokine Signaling Family Members 1/3 in Hepatitis B Virus Transgenic Mice

Tapasin modification on the intracellular epitope HBcAg18–27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo

TAT Protein Transduction Domain Mediates Transmembrane Delivery of BCR/ABL Fusion Protein into Tissue Cells of Mice in Vivo

Preparation and bioactivity of anti-Newcastle disease virus-phosphoprotein cytoplasmic transduction peptide antibody

Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo

Construction and Expression of TAT-NDPK-A Protein and Its Penetration into the Cells

TAT-Mediated Transmembrane Delivery of Fusion Protein into Different Organs and Skin in Mice

[Hbcag-Specific CTL Response Induced by PTD-HBcAg Fusion Protein to Inhibit HBV Replication in Vitro].